RBM16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.522500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.456400E-01
Normal-vs-Stage2
2.587900E-02
Normal-vs-Stage3
1.713240E-01
Normal-vs-Stage4
5.125800E-01
Stage1-vs-Stage2
5.552600E-01
Stage1-vs-Stage3
8.910400E-02
Stage1-vs-Stage4
5.169800E-01
Stage2-vs-Stage3
1.503230E-01
Stage2-vs-Stage4
1.996800E-01
Stage3-vs-Stage4
2.440100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.991790E-02
Normal-vs-AfricanAmerican
3.693200E-01
Normal-vs-Asian
1.136620E-01
Caucasian-vs-AfricanAmerican
2.285000E-01
Caucasian-vs-Asian
5.365600E-01
AfricanAmerican-vs-Asian
2.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.850170E-02
Normal-vs-Female
4.934300E-02
Male-vs-Female
3.652400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.810600E-01
Normal-vs-Age(41-60Yrs)
6.789900E-02
Normal-vs-Age(61-80Yrs)
2.483500E-02
Normal-vs-Age(81-100Yrs)
2.617600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.386600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.123800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.344600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.221950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.906160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.879550E-02
Normal-vs-Daily Drinker
6.482700E-03
Normal-vs-Weekly Drinker
4.562100E-02
Normal-vs-Occasional Drinker
8.018200E-02
Normal-vs-Social Drinker
1.835580E-01
Non Drinker-vs-Daily Drinker
3.947000E-01
Non Drinker-vs-Weekly Drinker
7.153800E-01
Non Drinker-vs-Occasional Drinker
3.421200E-01
Non Drinker-vs-Social Drinker
2.924200E-01
Daily Drinker-vs-Weekly Drinker
2.686400E-01
Daily Drinker-vs-Occasional Drinker
9.487800E-02
Daily Drinker-vs-Social Drinker
1.027570E-01
Weekly Drinker-vs-Occasional Drinker
6.232400E-01
Weekly Drinker-vs-Social Drinker
5.446000E-01
Occasional Drinker-vs-Social Drinker
8.335800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.356100E-02
Normal-vs-Grade 2
4.085700E-02
Normal-vs-Grade 3
2.542100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.291000E-01
Grade 1-vs-Grade 3
8.066000E-01
Grade 1-vs-Grade 4
9.356100E-02
Grade 2-vs-Grade 3
5.393800E-01
Grade 2-vs-Grade 4
4.085700E-02
Grade 3-vs-Grade 4
2.542100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.000340E-02
Normal-vs-NonDiabetic
1.552300E-02
Diabetic-vs-NonDiabetic
3.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.299600E-01
Normal-vs-NoPancreatitis
1.827780E-02
Pancreatitis-vs-NoPancreatitis
3.260600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.774500E-02
Normal-vs-N1
2.034000E-02
N0-vs-N1
9.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.483200E-01
Normal-vs-TP53-NonMutant
1.985450E-01
TP53-Mutant-vs-TP53-NonMutant
1.691560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
